Tenovin-D3

CAS No. 1258283-70-3

Tenovin-D3( Tenovin D3 )

Catalog No. M11063 CAS No. 1258283-70-3

A novel selective, small-molecule inhibitor of sirtuin SITR2 with IC50 of 21.8 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 873 Get Quote
50MG 1782 Get Quote
100MG 2250 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tenovin-D3
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel selective, small-molecule inhibitor of sirtuin SITR2 with IC50 of 21.8 uM.
  • Description
    A novel selective, small-molecule inhibitor of sirtuin SITR2 with IC50 of 21.8 uM; shows much weaker actvity for SIRT1 (IC50>90 uM), SIRT3 and HDAC8; promotes expression of the cell-cycle regulator and p53 target p21(WAF1/CIP1) (CDKN1A) in a p53-independent manner, fails to increase p53 levels or transcription factor activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Tenovin D3
  • Pathway
    Chromatin/Epigenetic
  • Target
    Sirtuin
  • Recptor
    Sirtuin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1258283-70-3
  • Formula Weight
    533.893
  • Molecular Formula
    C22H27Cl3N4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(NC(NC1=CC=C(NC(CCCCN(C)C)=O)C=C1)=S)C2=CC(Cl)=C(OC)C(Cl)=C2.[H]Cl
  • Chemical Name
    3,5-dichloro-N-((4-(5-(dimethylamino)pentanamido)phenyl)carbamothioyl)-4-methoxybenzamide hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. McCarthy AR, et al. Mol Cancer Ther. 2013 Apr;12(4):352-60. 2. Liu R, et al. Sci Rep. 2015 Feb 12;5:8415.
molnova catalog
related products
  • WAY-323061

    WAY-323061 is a SIRT2 inhibitor.

  • AK-7

    A potent, selective and brain-permeable SIRT2 inhibitor with IC50 of 15.5 uM.

  • Ophiopogonin D (b)

    Ophiopogonin D' can activate SIRT1 in a dose-dependent manner. Ophiopogonin D' also noncompetitively inhibits UGT1A6 and UGT1A10.